nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirenzepine—CHRM5—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.239	0.255	CbGpPWpGaD
Pirenzepine—CHRM1—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.168	0.18	CbGpPWpGaD
Pirenzepine—CHRM5—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0528	0.0564	CbGpPWpGaD
Pirenzepine—CHRM5—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0444	0.0474	CbGpPWpGaD
Pirenzepine—CHRM1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0372	0.0397	CbGpPWpGaD
Pirenzepine—CHRM5—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0324	0.0346	CbGpPWpGaD
Pirenzepine—CHRM1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0313	0.0334	CbGpPWpGaD
Pirenzepine—Olanzapine—CHRM3—nephrolithiasis	0.0297	0.467	CrCbGaD
Pirenzepine—CHRM1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0228	0.0244	CbGpPWpGaD
Pirenzepine—Loxapine—CHRM3—nephrolithiasis	0.0185	0.29	CrCbGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0182	0.0195	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.0163	0.0174	CbGpPWpGaD
Pirenzepine—CHRM5—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.0158	0.0169	CbGpPWpGaD
Pirenzepine—CHRM5—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.0158	0.0169	CbGpPWpGaD
Pirenzepine—Clozapine—CHRM3—nephrolithiasis	0.0155	0.243	CrCbGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.0132	0.0141	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0128	0.0137	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.0118	0.0126	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.0115	0.0123	CbGpPWpGaD
Pirenzepine—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.0111	0.0119	CbGpPWpGaD
Pirenzepine—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.0111	0.0119	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0102	0.0109	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00929	0.00992	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00874	0.00933	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00831	0.00887	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—RGS14—nephrolithiasis	0.0077	0.00822	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00718	0.00767	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—RGS14—nephrolithiasis	0.00699	0.00747	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—CHRM3—nephrolithiasis	0.00665	0.00711	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00615	0.00657	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—PTH—nephrolithiasis	0.00609	0.0065	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00542	0.00579	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—DGKH—nephrolithiasis	0.0052	0.00555	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.00492	0.00526	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ADCY10—nephrolithiasis	0.00486	0.00519	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—DGKH—nephrolithiasis	0.00472	0.00504	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00468	0.005	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.00428	0.00458	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—RGS14—nephrolithiasis	0.00413	0.00441	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00376	0.00402	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00366	0.00391	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—PTH—nephrolithiasis	0.00344	0.00367	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.00342	0.00365	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—CHRM3—nephrolithiasis	0.00341	0.00365	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	0.00333	0.00355	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—PTH—nephrolithiasis	0.00312	0.00334	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	0.00291	0.00311	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—DGKH—nephrolithiasis	0.00279	0.00298	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00279	0.00298	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00265	0.00283	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	0.00242	0.00259	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	0.0024	0.00257	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	0.0022	0.00235	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CHRM3—nephrolithiasis	0.00202	0.00215	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	0.00196	0.0021	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00196	0.0021	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PTH—nephrolithiasis	0.00184	0.00197	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	0.00142	0.00152	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PTH—nephrolithiasis	0.0013	0.00139	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—SPP1—nephrolithiasis	0.000926	0.000989	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	0.000652	0.000696	CbGpPWpGaD
